Extracellular vesicles (EVs), including exosomes, microvesicles, and oncosomes, are nano-
sized particles enclosed by a lipid bilayer. EVs are released by virtually all eukaryotic cells …

Parkinson's disease (PD) biomarkers are needed by both clinicians and researchers (for
diagnosis, identifying study populations, and monitoring therapeutic response). Imaging …

Extracellular vesicles (EVs) are cell-derived nanoparticles with an important role in
intercellular communication, even across brain barriers. The bidirectional brain-barrier …

Neuroinflammation, crucial in neurological disorders like Alzheimer's disease, multiple
sclerosis, and hepatic encephalopathy, involves complex immune responses. Extracellular …

Exosomes emerge from endosomal invagination and range in size from 30 to 200 nm.
Exosomes contain diverse proteins, lipids, and nucleic acids, which can indicate the state of …

Neurodegenerative disorders are one of the most common causes of disability and
represent 6.3% of the global burden of disease. Among them, Alzheimer's, Parkinson's, and …

Introduction: Alzheimer's disease (AD) is currently defined according to biomarkers reflecting
the core underlying neuropathological processes: Aβ deposition, Tau, and …

We are facing a growing aging population, along with increasing pressure on health
systems, caused by the impact of chronic co‐morbidities (ie cancer, cardiovascular and …

Blood‐derived extracellular vesicles (EVs) are a popular source of biomarkers for central
nervous system (CNS) diseases, but inconsistencies in isolation and analysis hinder their …

Abstract Background & Aims Parkinsonian disorders, such as Parkinson's disease (PD),
multiple system atrophy (MSA), dementia with Lewy bodies (DLB), progressive supranuclear …